Literature DB >> 18396389

How to concentrate nanoparticles and avoid aggregation?

C Vauthier1, B Cabane, D Labarre.   

Abstract

Most of the methods that are used to produce pharmaceutical suspensions of nanoparticles for drug-targeting yield suspensions having a low content in drug carriers. This can be a dramatic limitation when the volume of suspension that would have to be administered in vivo to reach therapeutic concentrations of the drug is much above the acceptable range. Concentrating the drug-carrier suspension by centrifugation, lyophilization and evaporation is often inapplicable because aggregates are formed. Here we present a simple method that is able to increase the concentration of nanoparticle suspensions without forming aggregates. It consists in a dialysis of the suspensions against a polymer solution. This causes an osmotic stress, which produces a displacement of water from the nanoparticle suspension towards the counter-dialysing solution. Various types of nanoparticle suspensions can be concentrated in near equilibrium conditions, and the result is controlled and reproducible. Concentration factors up to 50 were obtained in a few hours at room temperature. The original characteristics of the nanoparticles were fully preserved in the concentrated dispersion.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18396389     DOI: 10.1016/j.ejpb.2008.01.025

Source DB:  PubMed          Journal:  Eur J Pharm Biopharm        ISSN: 0939-6411            Impact factor:   5.571


  7 in total

Review 1.  Methods for the preparation and manufacture of polymeric nanoparticles.

Authors:  Christine Vauthier; Kawthar Bouchemal
Journal:  Pharm Res       Date:  2008-12-24       Impact factor: 4.200

2.  Antibiotic-Loaded Polymersomes for Clearance of Intracellular Burkholderia thailandensis.

Authors:  Eleanor Porges; Dominic Jenner; Adam W Taylor; James S P Harrison; Antonio De Grazia; Alethia R Hailes; Kimberley M Wright; Adam O Whelan; Isobel H Norville; Joann L Prior; Sumeet Mahajan; Caroline A Rowland; Tracey A Newman; Nicholas D Evans
Journal:  ACS Nano       Date:  2021-11-05       Impact factor: 15.881

3.  Preparation and characterization of polysaccharide-based nanoparticles with anticoagulant activity.

Authors:  Luiz Cláudio da Silva; Thiago Garcia; Michela Mori; Giuseppina Sandri; Maria Cristina Bonferoni; Priscila V Finotelli; Leonardo P Cinelli; Carla Caramella; Lúcio M Cabral
Journal:  Int J Nanomedicine       Date:  2012-06-18

4.  A method for concentrating lipid peptide DNA and siRNA nanocomplexes that retains their structure and transfection efficiency.

Authors:  Aristides D Tagalakis; Sara Castellaro; Haiyan Zhou; Alison Bienemann; Mustafa M Munye; David McCarthy; Edward A White; Stephen L Hart
Journal:  Int J Nanomedicine       Date:  2015-04-01

5.  Propolis particles incorporated in aqueous formulations with enhanced antibacterial performance.

Authors:  Nelli Chourmouziadi Laleni; Paulo De Carvalho Gomes; Konstantinos Gkatzionis; Fotis Spyropoulos
Journal:  Food Hydrocoll Health       Date:  2021

6.  Sample preparation considerations for surface and crystalline properties and ecotoxicity of bare and silica-coated magnetite nanoparticles.

Authors:  Lyubov Bondarenko; Vera Terekhova; Anne Kahru; Gulzhian Dzhardimalieva; Elena Kelbysheva; Natalya Tropskaya; Kamila Kydralieva
Journal:  RSC Adv       Date:  2021-09-29       Impact factor: 4.036

7.  Colloidal Stability of Silica-Modified Magnetite Nanoparticles: Comparison of Various Dispersion Techniques.

Authors:  Gulzhian Dzhardimalieva; Lyubov Bondarenko; Erzsébet Illés; Etelka Tombácz; Nataliya Tropskaya; Igor Magomedov; Alexander Orekhov; Kamila Kydralieva
Journal:  Nanomaterials (Basel)       Date:  2021-12-04       Impact factor: 5.076

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.